Skip to main content
. 2024 Dec 18;15:20420986241303432. doi: 10.1177/20420986241303432

Figure 8.

Figure 8.

Plasma concentration–time curves of aripiprazole and dehydro-aripiprazole after the administration of multiple oral 20 mg tablets of aripiprazole co-administration with risperidone in adults with mild hepatic impairment according to CYP2D6 phenotype, including CYP2D6 NM (a), IM (b), PM (c), and UM (d).

CP-A, Child-Pugh A; IM, intermediate metabolizer; NM, normal metabolizer; PM, poor metabolizer; UM, ultrarapid metabolizer.